Scribd
Upload
70 views

Lab Report New

Uploaded by

sajalmallick999
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
70 views

Lab Report New

Uploaded by

sajalmallick999
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 3

Lab No. : SIL/27-12-2024/MR0112675 Lab Add.

: Sevoke Road,Siliguri 734001

Patient Name : DIPALI CHAKRABORTY Ref Dr. : Dr.ANIRUDDHA GHOSH

Age : 59 Y 10 M 0 D Collection Date : 27/Dec/2024 01:44PM

Gender :F Report Date : 27/Dec/2024 06:45PM

DEPARTMENT OF BIOCHEMISTRY
Test Name Result Bio Ref. Interval Unit

GLUCOSE,PP , BLOOD, NAF PLASMA 816 75-140 mg/dl


(Method:Hexokinase Method)

CREATININE, BLOOD 2 0.5 - 1.1 mg/L


(Method: ALKALINE PICRATE )

*GLYCATED HAEMOGLOBIN (HBA1C) , EDTA WHOLE BLOOD


GLYCATED HEMOGLOBIN (HBA1C) 12.9 ***FOR BIOLOGICAL REFERENCE %
INTERVAL DETAILS , PLEASE
REFER TO THE BELOW
MENTIONED REMARKS/NOTE
WITH ADDITIONAL CLINICAL
INFORMATION ***
HbA1c (IFCC) 118 mmol/mol
(Method:HPLC)

Clinical Information and Laboratory clinical interpretation on Biological Reference Interval:


Low risk / Normal / non-diabetic : <5.7% (NGSP) / < 39 mmol/mol (IFCC)
Pre-diabetes/High risk of Diabetes : 5.7%- 6.4% (NGSP) / 39 - < 48 mmol/mol (IFCC)
Diabetics-HbA1c level : >/= 6.5% (NGSP) / > 48 mmol/mol (IFCC)

Analyzer used : Bio-Rad D 10


Method : HPLC Cation Exchange

Recommendations for glycemic targets


Ø Patients should use self-monitoring of blood glucose (SMBG) and HbA1c levels to assess glycemic control.
Ø The timing and frequency of SMBG should be tailored based on patients' individual treatment, needs, and goals.
Ø Patients should undergo HbA1c testing at least twice a year if they are meeting treatment goals and have stable glycemic control.
Ø If a patient changes treatment plans or does not meet his or her glycemic goals, HbA1c testing should be done quarterly.
Ø For most adults who are not pregnant, HbA1c levels should be <7% to help reduce microvascular complications and macrovascular
disease . Action suggested >8% as it indicates poor control.
Ø Some patients may benefit from HbA1c goals that are stringent.
Result alterations in the estimation has been established in many circumstances, such as after acute/ chronic blood loss, for example, after
surgery, blood transfusions, hemolytic anemia, or high erythrocyte turnover; vitamin B12/ folate deficiency, presence of chronic renal or liver
disease; after administration of high-dose vitamin E / C; or erythropoietin treatment.
Reference: Glycated hemoglobin monitoring BMJ 2006; 333;586-8

References:
1. Chamberlain JJ, Rhinehart AS, Shaefer CF, et al. Diagnosis and management of diabetes: synopsis of the 2016 American Diabetes Association Standards of Medical Care
in Diabetes. Ann Intern Med. Published online 1 March 2016. doi:10.7326/M15-3016.
2. Mosca A, Goodall I, Hoshino T, Jeppsson JO, John WG, Little RR, Miedema K, Myers GL, Reinauer H, Sacks DB, Weykamp CW. International Federation of Clinical
Chemistry and Laboratory Medicine, IFCC Scientific Division. Global standardization of glycated hemoglobin measurement: the position of the IFCC Working Group. Clin Chem
Lab Med. 2007;45(8):1077-1080.

PDF Attached

Page 1 of 2
Lab No. : SIL/27-12-2024/MR0112675 Lab Add. : Sevoke Road,Siliguri 734001

Patient Name : DIPALI CHAKRABORTY Ref Dr. : Dr.ANIRUDDHA GHOSH

Age : 59 Y 10 M 0 D Collection Date : 27/Dec/2024 01:44PM

Gender :F Report Date : 27/Dec/2024 06:45PM

DEPARTMENT OF BIOCHEMISTRY
Test Name Result Bio Ref. Interval Unit

Lab No. : SIL/27-12-2024/MR0112675 Page 2 of 2


SURAKSHA DIAGNOSTIC PVT LTD
15/10 UDHAM SINGH SARANI -SILIGURI-734401

Patient report

Sample ID: E02132019516


Injection date 27/12/2024 07:13 PM
Injection #: 59 D-10 Method: HbA1c
Rack #: --- Rack position: 4
Bio-Rad v: 5.00-2 S/N: #DM23F10804

Peak table - ID: E02132019516


Peak R.time Height Area Area %
A1a 0.23 6788 35212 1.5
A1b 0.33 12211 70894 3.1
LA1c/CHb-1 0.65 19048 130134 5.6
A1c 0.85 27022 237414 12.9
P3 1.30 80532 228436 9.9
A0 1.40 698671 1606176 69.6
Total Area: 2308266

Concentration: % mmol/mol
A1c 12.9 118

You might also like